EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

High-Multiplex Aptamer-Based Serum Proteomics to Identify Candidate Serum Biomarkers of Oral Squamous Cell Carcinoma

Sebastian Blatt, Peer W Kämmerer iD, Maximilian Krüger, Rambabu Surabattula, Daniel G E Thiem iD, Simon T Dillon, Bilal Al-Nawas iD, Towia A Libermann iD, Detlef Schuppan

Cancers · 30.03.2023 · 15 (7) · 2071

DOI: 10.3390/cancers15072071 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancers, online erschienen am 30.03.2023. Verfasst von Sebastian Blatt und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Maxillofacial Surgery, University Medical Center, 55131 Mainz, Germany. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University Medical Centre Mainz.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Improved serological biomarkers are needed for the early detection, risk stratification and treatment surveillance of patients with oral squamous cell carcinoma (OSCC). We performed an exploratory study using advanced, highly specific, DNA-aptamer-based serum proteomics (SOMAscan, 1305-plex) to identify distinct proteomic changes in patients with OSCC pre- vs. post-resection and compared to healthy controls. A total of 63 significantly differentially expressed serum proteins (each p < 0.05) were found that could discriminate between OSCC and healthy controls with 100% accuracy. Furthermore, 121 proteins were detected that were significantly altered between pre- and post-resection sera, and 12 OSCC-associated proteins reversed to levels equivalent to healthy controls after resection. Of these, 6 were increased and 6 were decreased relative to healthy controls, highlighting the potential relevance of these proteins as OSCC tumor markers. Pathway analyses revealed potential pathophysiological mechanisms associated with OSCC. Hence, quantitative proteome analysis using SOMAscan technology is promising and may aid in the development of defined serum marker assays to predict tumor occurrence, progression and recurrence in OSCC, and to guide personalized therapies.

Schlagwörter

Stichwörter der Autor:innen

SOMAscanbiomarkerliquid biopsyoral cancerprognosisproteomicsserumtherapy

Autor:innen und Institutionen

  • Department of Oral and Maxillofacial Surgery, University Medical Center, 55131 Mainz, Germany.
  • Institute of Translational Immunology and Research Center for Immune Therapy (FZI), University Medical Center of the Johannes Gutenberg-University, 55131 Mainz, Germany.
  • Beth Israel Deaconess Medical Center Genomics, Proteomics, Bioinformatics and Systems Biology Center, Division of Interdisciplinary Medicine and Biotechnology, Beth Israel Deaconess Medical Center, Harvard Medical Schoo…
  • Division of Gastroenterology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.

ORCID-Profile: Peer W Kämmerer, Daniel G E Thiem, Bilal Al-Nawas, Towia A Libermann

Förderung

  • University Medical Centre Mainz

Zitieren

APA

Blatt, S., Kämmerer, P. W., Krüger, M., Surabattula, R., Thiem, D. G. E., Dillon, S. T., Al-Nawas, B., Libermann, T. A., & Schuppan, D. (2023). High-Multiplex Aptamer-Based Serum Proteomics to Identify Candidate Serum Biomarkers of Oral Squamous Cell Carcinoma. Cancers, 15(7), 2071. https://doi.org/10.3390/cancers15072071

Vancouver

Blatt S, Kämmerer PW, Krüger M, Surabattula R, Thiem DGE, Dillon ST, et al. High-Multiplex Aptamer-Based Serum Proteomics to Identify Candidate Serum Biomarkers of Oral Squamous Cell Carcinoma. Cancers. 2023;15(7):2071. doi:10.3390/cancers15072071

BibTeX
@article{Blatt2023,
  author = {Blatt, Sebastian and Kämmerer, Peer W and Krüger, Maximilian and Surabattula, Rambabu and Thiem, Daniel G E and Dillon, Simon T and Al-Nawas, Bilal and Libermann, Towia A and Schuppan, Detlef},
  title = {High-Multiplex Aptamer-Based Serum Proteomics to Identify Candidate Serum Biomarkers of Oral Squamous Cell Carcinoma},
  journal = {Cancers},
  year = {2023},
  volume = {15},
  number = {7},
  pages = {2071},
  doi = {10.3390/cancers15072071}
}
Kostenlos starten →